C4 Therapeutics, Inc.

NASDAQ:CCCC

5.51 (USD) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -132.493-128.175-83.892-66.335-34.099-15.711
Depreciation & Amortization 7.7371.6761.4921.6171.5951.273
Deferred Income Tax 10.05401.8795.5810.350.066
Stock Based Compensation 27.23530.01621.5123.4321.6420.582
Change In Working Capital -6.938-16.779-30.09-13.17784.982-5.559
Accounts Receivables -10.3274.244-1.2320.13981.815-84.944
Inventory 00-2.627-1.582.171-2.222
Accounts Payables 0.273-3.333-1.1790.4674.2310.578
Other Working Capital 3.116-17.69-25.052-12.203-3.23581.029
Other Non Cash Items -12.4337.3232.1341.6331.1442.368
Operating Cash Flow -106.838-105.939-86.965-67.24955.614-16.981
Investing Activities:
Investments In Property Plant And Equipment -1.708-5.496-1.277-0.65-1.349-2.689
Acquisitions Net -160.057-63.918188.059189.8550.0630
Purchases Of Investments -129.898-219.527-537.74-293.855-79-4.99
Sales Maturities Of Investments 289.955283.445349.68110478.66644.6
Other Investing Activites 160.05763.918-188.059-189.855-0.27139.61
Investing Cash Flow 158.34958.422-189.336-190.505-1.6236.921
Financing Activities:
Debt Repayment 000000
Common Stock Issued 57.7310.777169.465340.5990.2740.047
Common Stock Repurchased -0.1100-0.194-0.03-0.063
Dividends Paid 000000
Other Financing Activities 0.3680.371.93532.473-0.031.914
Financing Cash Flow 45.4891.147171.4348.9320.2441.961
Other Information:
Effect Of Forex Changes On Cash -0.16400000
Net Change In Cash 96.836-46.37-104.90191.17854.23821.901
Cash At End Of Period 126.5933.03379.403184.30493.12638.888